Germany had the largest Arthroscopy Devices Market Share, accounting for approximately US$ 1.9 Billion.

 The Arthroscopy Devices Market is expected to reach US$ 5.61 billion in 2022, growing at a 7.1% CAGR from 2022 to 2032.

Each year orthopaedic surgeons perform more than five million arthroscopies. Due to the continuous growth and aging of global population, there will be a steady demand for both emerging as well as established arthroscopy devices.

Gain complete access to the report @ https://www.futuremarketinsights.com/reports/arthroscopy-devices-market

Knee and shoulder arthroscopy remain most common arthroscopic procedures worldwide. Most large or medium size joints, such as knees and shoulders are repaired by arthroscopic approaches. Surgery that years ago was able through an open approach now can be done via an arthroscopic approach, with similar long term outcomes, low post-operative pain, and reducing hospital stays.

Global Arthroscopic Devices Market: Drivers & Restraints

The arthroscopic devices market has emerged as one of the attractive industries in the medical equipment sector. In the recent past, the orthopaedics industry has seen major private equity transactions, several mergers and innovative product launches which acts as a key driver for global arthroscopic devices market. Rise of aging population along with advancement in technology especially in medical and healthcare sector is likely to fuel arthroscopic devices market.

As consumers have become more health conscious and prefer high layout for orthopaedic treatments, global arthroscopic devices market is likely to project a promising future over the forecast period. A growing geriatric population worldwide has boosted the demand for arthroscopic devices and treatment globally. Increasing use of robotics creates more potential for arthroscopic devices market.

Global Arthroscopic Devices Market: Region-wise Outlook

In terms of geography, the global arthroscopic devices market has been divided in to seven key regions including North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Middle East & Africa and Japan.

The global arthroscopic devices market is expected to register healthy CAGR during the forecast period and offers considerable commercial potential. However regions of Latin America and emerging economies of Asia-Pacific are major hotspots for global arthroscopic devices market. Technological advancement have brought rapid growth in the Europe and North America market.Asia-Pacific countries such as India and China have high growth rate due to low taxation, rise in disposable incomes and investment friendly environment accelerating the growth of arthroscopic devices market in Asia-pacific.

Key companies profiled: 

  • Arthrex, Inc.
  • Conmed Corporation, 
  • Johnson & Johnson,
  • KARL STORZ GmbH & Co. KG,
  • Medtronic, Plc,
  • Richard Wolf GmbH,
  • Smith & Nephew, Plc,
  •  Stryker Corporation,
  • Wright Medical Group N.V.,
  • Zimmer Biomet Holdings, Inc.

Key Segments

By Procedure:

  • Shoulder Arthroscopic procedure
  • Knee Arthroscopic procedure
  • Hip Arthroscopic procedure
  • Others

By Product Type:

  • Arthroscopes
  • Arthroscopic Implants
  • Shoulder Implants
  • Knee Implants
  • Hip Implants
  • Small joint Implants
  • Arthroscopic shaver systems
  • Arthroscopic visualization
  • Fluid management systems
  • Arthroscopic Radio Frequency Devices
  • Arthroscopic Radio Frequency Systems
  • Arthroscopic Radio Frequency Wands

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more